Live Breaking News & Updates on அல்லேஜிஹினி ஆரோக்கியம் வலைப்பின்னல் மருந்து நிறுவனம்|Page 1

Stay updated with breaking news from அல்லேஜிஹினி ஆரோக்கியம் வலைப்பின்னல் மருந்து நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lupus Foundation of America Unites Nationwide Lupus Community to Make an Impact for Lupus Awareness Month this May


Lupus Foundation of America Unites Nationwide Lupus Community to Make an Impact for Lupus Awareness Month this May
Throughout May, the Foundation will lead the effort to raise lupus awareness and make lupus visible
News provided by
Share this article
Share this article
WASHINGTON, April 30, 2021 /PRNewswire/ This May for Lupus Awareness Month, the Lupus Foundation of America will continue its effort to
Make Lupus Visible, encouraging lupus warriors, family members and friends to raise awareness for the often invisible and devastating disease while also raising funds to support lupus research, education programs and support services.
Over half of Americans (63%) have never heard of or know little or nothing about lupus, underscoring the urgent need to raise awareness of the disease s brutal impact on every part of a person s life. Because many symptoms and effects of lupus are invisible, it can often leave those living with lupus feeling misunderstood ....

United States , Susanm Manzi , Stevanw Gibson , Maggie Maloney , Lupus Foundation Of America , Aurinia Pharmaceuticals , Allegheny Health Network Medicine Institute , Lupus Foundation Of America Board , Lupus Center , Lupus Awareness Month , Lupus Foundation , Make Lupus Visible , America Board Chair , Medical Director , Make Lupus , Purple Dayon May , Master Spas , ஒன்றுபட்டது மாநிலங்களில் , மாகி மலோநீ , லூபஸ் அடித்தளம் ஆஃப் அமெரிக்கா , ஒரினிய மருந்துகள் , அல்லேஜிஹினி ஆரோக்கியம் வலைப்பின்னல் மருந்து நிறுவனம் , லூபஸ் அடித்தளம் ஆஃப் அமெரிக்கா பலகை , லூபஸ் மையம் , லூபஸ் விழிப்புணர்வு மாதம் , லூபஸ் அடித்தளம் ,

Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis


Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis
First FDA-approved oral treatment for lupus nephritis represents a significant milestone for people living with lupus-related kidney disease, a leading cause of disability and mortality in lupus
News provided by
Share this article
Share this article
WASHINGTON, Jan. 22, 2021 /PRNewswire/   For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new medication to treat adults with lupus nephritis (lupus-related kidney disease) in combination with a background immunosuppressive therapy regimen. Today, Aurinia Pharmaceuticals announced they received authorization from the FDA to market Lupkynis™ (voclosporin), a first-ever oral therapy for lupus nephritis that blocks a protein in the immune system called calcineurin. The company previously had reported positive data from a late- ....

United States , Susanm Manzi , Monique Gore Massy , Karenh Costenbader , Stevanw Gibson , Mike Donnelly , Lupus Foundation Of America Ambassador , Drug Administration , Allegheny Health Network Medicine Institute , Scientific Advisory Council , Lupus Program At Brigham , Aurinia Pharmaceuticals , Lupus Foundation Of America , Lupus Center , Lupus Foundation , Board Chair , Medical Director , Lupus Program , Medical Scientific Advisory Council , Research Accelerated , ஒன்றுபட்டது மாநிலங்களில் , மொநீக் கார் வெகுஜன , மைக் டோநிலீ , லூபஸ் அடித்தளம் ஆஃப் அமெரிக்கா தூதர் , அல்லேஜிஹினி ஆரோக்கியம் வலைப்பின்னல் மருந்து நிறுவனம் , லூபஸ் ப்ரோக்ர்யாம் இல் ப்ரிகாம் ,